| ²é¿´: 695 | »Ø¸´: 2 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
Õź£Àò1025¾èÖú¹ó±ö (ÕýʽдÊÖ)
|
[ÇóÖú]
Çóceritinib¼°ÆäÖмäÌåµÄºÏ³É·Ïß ÒÑÓÐ1È˲ÎÓë
|
|
|
Çóceritinib¼°ÆäÖмäÌåµÄºÏ³É·Ïߣ¬×îºÃÓÐÏà¹ØÎÄÏײο¼£¬½ð±ÒºÜÉÙ£¬³ÏÐÄÇóÖú¡£ Ceritinib(É«ÈðÌæÄá)2014Äê4ÔÂ29ÈÕFDAÅú×¼µÄ¿¹°©Ò©¡£CeritinibshiÊÇALKÒÖÖÆ¼Á(Anaplastic Lymphoma Kinase),ÓÃÓÚ¾crizotinibÖÎÁƺó²¡Çé¶ñ»¯»ò¶Ôcrizotinib²»ÄÍÊܵļä±äÐÔÁܰÍÁö¼¤Ã¸ÑôÐÔ£¨ALK+£©×ªÒÆÐÔ·ÇСϸ°û·Î°©£¨NSCLC£©»¼ÕßµÄÖÎÁÆ¡£ÉÌÆ·ÃûZykadia,ÓÉŵ»ªÖÆÒ©¹«Ë¾Ñз¢¡£ ÉÌÆ·Ãû: Zykadia® Ó¢ÎÄÃû: Ceritinib Capsules £¨ÔøÓÃÃû£ºLDK378£© Æä»¯Ñ§Ãû³ÆÎª: 5-Chloro-N2-[2-isopropoxy-5-methyl-4-(4-piperidinyl)phenyl]-N4-[2-(isopropylsulfonyl)phenyl]-2,4-pyrimidinediamine ·Ö×Óʽ£ºC28H36N5O3ClS ·Ö×ÓÁ¿£º558.14 |
» ²ÂÄãϲ»¶
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ7È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ11È˻ظ´
ΪʲôÖйú´óѧ¹¤¿Æ½ÌÊÚÃÇË®ÁËÄÇô¶àËùνµÄ¶¥»á¶¥¿¯£¬µ«»¹ÊÇ×ö²»³öÓîÊ÷»úÆ÷ÈË£¿
ÒѾÓÐ8È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ6È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ9È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ4È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8 O5 51O 54,¿ÆÄ¿ÆëÈ«,¿É+¼±
ÒѾÓÐ5È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

l-warrior
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1541.8
- É¢½ð: 320
- Ìû×Ó: 164
- ÔÚÏß: 170.1Сʱ
- ³æºÅ: 2317404
- ×¢²á: 2013-03-04
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
3Â¥2015-05-05 10:09:25
Ã÷Ã÷ÊÇÃ÷Ã÷
гæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2.3
- Ìû×Ó: 10
- ÔÚÏß: 4.2Сʱ
- ³æºÅ: 3821417
- ×¢²á: 2015-04-20
- רҵ: Ò©Îﻯѧ
2Â¥2015-04-30 11:38:56













»Ø¸´´ËÂ¥